to beginning the research process for Competitive
Benchmarking of Leading Pharmaceutical Companies’ Strategies for
Leveraging the Field Medical Function: Approaches for Engaging Clinicians and
Payers, PharmaForce International conducted detailed interviews
with Field Medical Affairs (FMA) leadership to understand the most critical
issues facing them in 2016.
decisions about the therapeutic options available for patient care are made
less and less at the physician level, some pharmaceutical companies have
initiated a strategic shift to focus their FMA efforts on the payer level. The report provides up-to-date and
in-depth company-specific analysis on how companies are adapting to this
historic shift in power.
the traditional therapeutic area Medical Science Liaison (MSL), companies are
deploying an array of FMA personnel: Health Economics Outcomes Research (HEOR),
Field Medical Physicians and payer-specific MSLs.
the value of these FMA personnel to the customer and to the company is also
explored: What quantitative
information is assessed to determine qualitative excellence in MSL performance?
The primary research conducted by PharmaForce professionals provides insights and value far
beyond the typical offerings, which tend to rely largely on secondary
research. Most key insights in the
report are a result of in-depth conversations with knowledgeable industry
Upon request, PharmaForce
International will send a sample company report from Competitive Benchmarking of Leading
Pharmaceutical Companies’ Strategies for Leveraging the Medical Liaison
Function: Approaches for Engaging
Clinicians and Payers to prospective clients.
A page entitled “Key Changes Since the Previous Report” begins the section
for all profiled companies. The balance of each company section identifies
relevant and strategic developments along with up-to-date information on the
o Heavily populated
with primary research findings
in creating materials for use in the field
information with Sales
methods and metrics
o Rewarding excellence
roles and responsibilities
To order, request a full list of the
companies covered, or learn more about the study and the research methodology,
please feel free to reply to this email or contact me by phone at 610-370-5640.
PFI’s ”Market Access Structures and Strategies: Leading Pharmaceutical
Companies’ Approaches” rounds out the
complete Market Access perspective, as
it explores how select pharmaceutical companies deploy field-based functions
such as Account Executives and Reimbursement personnel. Should you have interest in both reports, a bundling discount can be applied.
more Information, please contact Lorrie Berg-Henne at email@example.com or
by phone at 610-370-2906 ext. 109